Division of Cardiothoracic and Vascular Surgery, New York Presbyterian Hospital, Columbia University Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Gen Thorac Cardiovasc Surg. 2023 Aug;71(8):455-463. doi: 10.1007/s11748-023-01907-w. Epub 2023 Feb 6.
To determine the role of adding open distal anastomosis to proximal aortic aneurysm repairs in bicuspid aortic valve (BAV) patients.
Retrospective review was performed of 1132 patients at our Aortic Center between 2005 and 2019. Inclusion criteria were all patients diagnosed with a BAV who underwent proximal aortic aneurysm repair with open or clamped distal anastomosis. Exclusion criteria were patients without a BAV, age < 18 years, aortic arch diameter ≥ 4.5 cm, type A aortic dissection, previous ascending aortic replacement, ruptured aneurysm, and endocarditis. Propensity score matching in a 2:1 ratio (220 clamped: 121 open repairs) on 18 variables was performed.
Median follow-up time was 45.6 months (range 7.2-143.4 months). In the matched groups, no significant differences were observed between the respective open and clamped distal anastomosis groups for Kaplan Meier 10-year survival (86.9% vs. 92.9%; p = 0.05) and landmark survival analysis after 1 year (90.6%; vs. 93.3%; p = 0.39). Overall incidence of aortic arch-related reintervention was low (n = 3 total events). In-hospital complications were not significantly different in the open with respect to the clamped repair group, including in-hospital mortality (2.5% vs. 0.5%; p = 0.13) and stroke (0% vs. 0.9%; p = 0.54). In multivariable analysis, open distal anastomosis repair was not associated with long-term mortality (Hazard Ratio (HR) 1.98; p = 0.06).
We found no significant inter-group differences in survival, reintervention, or in-hospital complication rates, with low rates of mortality, and aortic arch-related reintervention, suggesting adding open distal anastomosis may not provide benefit in BAV patients undergoing proximal aortic aneurysm repairs.
确定在二叶式主动脉瓣(BAV)患者中行近端主动脉瘤修复时加行开放远端吻合术的作用。
对 2005 年至 2019 年期间在我院主动脉中心的 1132 例患者进行回顾性研究。纳入标准为所有诊断为 BAV 且行近端主动脉瘤修复术伴开放或夹闭远端吻合术的患者。排除标准为无 BAV、年龄<18 岁、主动脉弓直径≥4.5cm、A型主动脉夹层、既往升主动脉置换术、破裂性动脉瘤和心内膜炎。对 18 个变量进行了 2:1 比例(夹闭组 220 例,开放组 121 例)的倾向评分匹配。
中位随访时间为 45.6 个月(7.2-143.4 个月)。在匹配组中,开放和夹闭远端吻合术组之间的 Kaplan-Meier 10 年生存率(86.9% vs. 92.9%;p=0.05)和 1 年后的生存标志分析(90.6% vs. 93.3%;p=0.39)无显著差异。主动脉弓相关再介入的总体发生率较低(共 3 例)。开放组与夹闭组的院内并发症无显著差异,包括院内死亡率(2.5% vs. 0.5%;p=0.13)和卒中(0% vs. 0.9%;p=0.54)。多变量分析显示,开放远端吻合术修复与长期死亡率无关(风险比(HR)1.98;p=0.06)。
我们发现两组间在生存率、再介入率或院内并发症发生率方面无显著差异,死亡率和主动脉弓相关再介入率均较低,这表明在 BAV 患者中行近端主动脉瘤修复时加行开放远端吻合术可能无法获益。